Supply of NIV Drugs to Directorate of Procurement (Navy), Islamabad

The Directorate of Procurement (Navy), Islamabad, invites sealed bids from original manufacturers, authorized distributors, and suppliers registered with income tax and sales tax departments for the supply of NIV Drugs as per the detailed schedule in DP-2 form. This procurement covers 18 specific drug items including Beclomethasone Nasal Spray, Latanoprost Eye Drops, Natamycin Eye Drops, Dexamethasone + Ofloxacin Eye Drops, Tranexamic Acid in various dosages and forms, IVIG G, Antirabies Human Immunoglobulin, Mycophenolate Mofetil, Doxorubicin, Letrozole, Cisplatin, Gemcitabine, and Ifosfamide. Items being procured: - Beclomethasone Nasal Spray 100 MCG (7,000 units) - Latanoprost Eye Drops 0.01% (4,000 units) - Natamycin 5% Eye Drops 5 ML (2,000 units) - Dexamethasone + Ofloxacin Eye Drops 0.1/0.3% 5 ML (1,500 units) - Tranexamic Acid 250 MG Tablets/Capsules (50,000 units) - Tranexamic Acid 500 MG Tablets/Capsules (100,000 units) - Tranexamic Acid 250 MG Ampoules/Vials (15,000 units) - Tranexamic Acid 500 MG Ampoules/Vials (25,000 units) - IVIG G 10 ML Ampoules/Vials (600 units) - Antirabies Human Immunoglobulin 1000 IU 5 ML Ampoules/Vials (1,500 units) - Mycophenolate Mofetil 500 MG Tablets/Capsules (60,000 units) - Doxorubicin 50 MG Ampoules/Vials (250 units) - Letrozole 2.5 MG Tablets/Capsules (15,000 units) - Cisplatin 10 MG Ampoules/Vials (250 units) - Gemcitabine 1 G Ampoules/Vials (200 units) - Gemcitabine 200 MG Ampoules/Vials (250 units) - Ifosfamide 2 G Ampoules/Vials (150 units) - Ifosfamide 1 G Ampoules/Vials (250 units) The technical scope requires compliance with detailed specifications, shelf life requirements, packaging standards, and delivery schedules for the fiscal year 2027-28. Delivery will be on a supply order basis with inspection by Pakistan Navy Medical Stores Depot at Karachi and Islamabad. Firms must be registered or willing to register with DGDP and be on the Active Taxpayers List (ATL) of FBR. Earnest money in the form of CDR is mandatory and must be submitted in a separate sealed envelope. The tender follows a Single Stage - Two Envelope bidding procedure with technical offers evaluated first. Bidders should ensure all required documents including technical offers, commercial offers, registration certificates, and earnest money are submitted as per instructions. The tender closing date is **05 November 2026 at 1030 hours** with opening at 1100 hours the same day at the Directorate of Procurement (Navy), Sector E-8, Islamabad. Bids must be dropped in Tender Box No. 206. Late submissions will not be entertained. A practical tip for bidders: Carefully prepare your technical offer strictly following Annex-A of DP-2 and ensure all compliance documents and certifications are attached to avoid rejection during technical evaluation. Also, confirm your firm's DGDP registration status and maintain the validity of your bid for at least 120 days. This procurement offers a significant opportunity for pharmaceutical suppliers to serve the Pakistan Navy with essential medical supplies under transparent and regulated conditions.